RFK Jr. Pressed on Autism Claims and Health Cuts in House Hearing

Robert F. Kennedy Jr. testified at a House hearing this week in Washington, D.C., defending his health agenda and support for President Trump’s proposed budget cuts as lawmakers pressed him over controversial public statements and policy choices. Republicans, including Rep. Blake Moore — whose son is autistic — challenged Kennedy’s and Trump’s September suggestion that prenatal acetaminophen (Tylenol) use causes autism, calling the resulting report underwhelming and hurtful to families; Democrats confronted him over canceling pro‑vaccine public‑service campaigns during active measles outbreaks and replacing them with a taxpayer‑funded ad featuring Kennedy alongside entertainer Kid Rock, and they also pressed him about staffing gaps at HHS, including unfilled CDC director and surgeon general posts amid ongoing outbreaks. The hearing, described by one outlet as the first of several contentious sessions, also featured Kennedy disputing a recorded podcast in which he allegedly suggested sending Black boys to “wellness farms,” saying he did not know the phrase despite the tape’s existence.

Contextual public‑health data complicates the claims and the politics. Autism affects a substantial share of children in the U.S.; CDC estimates put prevalence among 8‑year‑olds at about 1 in 31 (3.2%) as of 2025, and scientific consensus attributes autism to a complex mix of primarily genetic factors with no single identified cause. Recent large studies, including a 2026 Danish nationwide analysis, found no association between acetaminophen use during pregnancy and autism risk, undermining the causal link advanced by some officials. At the same time, the U.S. is grappling with 1,714 confirmed measles cases across 17 outbreaks in early 2026, a context critics say made canceling pro‑vaccine messaging particularly risky. Debate over budget cuts also has tangible implications for services: programs like WIC served about 6.3 million participants monthly in recent years and reached roughly 56% of eligible individuals in 2023, illustrating how funding changes could affect large populations.

Social media responses were polarized: some accounts celebrated Kennedy’s efforts to investigate alleged fraud and to validate parents’ concerns, pointing to announced recoveries of healthcare fraud and new autism studies, while others flagged appointments and associations they view as dangerous — one retired pediatrician account criticized Kennedy’s appointment of David Geier — and still others defended him against what they call misattribution of responsibility for outbreaks. Coverage itself appears to be shifting: earlier reporting often amplified Kennedy’s inquiries into vaccine and environmental links to autism, but recent accounts have grown more scrutinizing, emphasizing contradictions in his testimony, the absence of supporting science for certain claims, and the potential public‑health consequences of his policy choices. Outlets pressing those lines of questioning — notably the more critical reporting in MS NOW alongside mainstream coverage such as NPR’s hearings reporting — have helped move the conversation from policy promotion to close oversight and fact‑checking.